McKinnon Nicholas D, Azad Alvi, Waters Brian M, Joshi Kaustubh G
US Air Force (Wilford Hall Medical Center, Lackland AFB, Texas) and the University of Texas Health Science Center at San Antonio, Texas, USA.
Psychiatry (Edgmont). 2009 Mar;6(3):30-5.
Resistant schizophrenia is often treated with clozapine after other conventional atypical antipsychotics have failed or have resulted in intolerable side effects. Clozapine is generally reserved for secondary use due to its propensity to cause serious side effects, such as life-threatening agranulocytosis and the necessity for life-long blood monitoring. In this case report we present a 40-year-old female patient who suffered from chronic constipation and bowel infarctions after long-term use with clozapine. Although the use of this medication resulted in multiple abdominal surgeries with subtotal colonic resections, the patient's schizophrenic symptoms only responded to clozapine after several repeat failures with other medications; ultimately, she was continued on this medication.
在其他传统非典型抗精神病药物治疗失败或产生无法耐受的副作用后,难治性精神分裂症通常采用氯氮平治疗。由于氯氮平有引发严重副作用的倾向,如危及生命的粒细胞缺乏症,以及需要终身进行血液监测,所以一般留作二线用药。在本病例报告中,我们介绍了一名40岁的女性患者,她在长期使用氯氮平后出现了慢性便秘和肠梗死。尽管使用这种药物导致多次腹部手术并进行了结肠次全切除术,但该患者的精神分裂症症状在其他药物多次反复治疗失败后仅对氯氮平有反应;最终,她继续使用这种药物。